Literature DB >> 27381816

Bicarbonate and mannitol treatment for traumatic rhabdomyolysis revisited.

Jamison S Nielsen1, Mitchell Sally2, Richard J Mullins1, Matthew Slater1, Tahnee Groat3, Xiang Gao1, J Salvador de la Cruz1, Margaret K M Ellis1, Martin Schreiber1, Darren J Malinoski4.   

Abstract

BACKGROUND: A rhabdomyolysis protocol (RP) with mannitol and bicarbonate to prevent acute renal dysfunction (ARD, creatinine >2.0 mg/dL) remains controversial.
METHODS: Patients with creatine kinase (CK) greater than 2,000 U/L over a 10-year period were identified. Shock, Injury Severity Score, massive transfusion, intravenous contrast exposure, and RP use were evaluated. RP was initiated for a CK greater than 10,000 U/L (first half of the study) or greater than 20,000 U/L (second half). Multivariable analyses were used to identify predictors of ARD and the independent effect of the RP.
RESULTS: Seventy-seven patients were identified, 24 (31%) developed ARD, and 4 (5%) required hemodialysis. After controlling for other risk factors, peak CK greater than 10,000 U/L (odds ratio 8.6, P = .016) and failure to implement RP (odds ratio 5.7, P = .030) were independent predictors of ARD. Among patients with CK greater than 10,000, ARD developed in 26% of patients with the RP versus 70% without it (P = .008).
CONCLUSION: Reduced ARD was noted with RP. A prospective controlled study is still warranted. Published by Elsevier Inc.

Entities:  

Keywords:  Acute kidney injury; Alkaline diuresis; Creatine kinase; Mannitol; Rhabdomyolysis

Mesh:

Substances:

Year:  2016        PMID: 27381816     DOI: 10.1016/j.amjsurg.2016.03.017

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

Review 1.  A "crush" course on rhabdomyolysis: risk stratification and clinical management update for the perioperative clinician.

Authors:  Devan R Cote; Eva Fuentes; Ali H Elsayes; Jonathan J Ross; Sadeq A Quraishi
Journal:  J Anesth       Date:  2020-05-18       Impact factor: 2.078

2.  Rhabdomyolysis and Acute Kidney Injury Associated With Terbinafine Use: A Case Report.

Authors:  Shijie Zhou; Amit Bagga
Journal:  Can J Kidney Health Dis       Date:  2020-10-22

3.  Serum creatine kinase levels are not associated with an increased need for continuous renal replacement therapy in patients with acute kidney injury following rhabdomyolysis.

Authors:  Luniu Xiao; Xiao Ran; Yanxia Zhong; Yue Le; Shusheng Li
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

4.  Amputation in crush syndrome: A case report.

Authors:  María Camila Arango-Granados; Diego Fernando Cruz Mendoza; Alexander Ernesto Salcedo Cadavid; Alberto Federico García Marín
Journal:  Int J Surg Case Rep       Date:  2020-06-12

Review 5.  Role of Bicarbonates and Mannitol in Rhabdomyolysis: A Comprehensive Review.

Authors:  Manoj R Somagutta; Sukrut Pagad; Saijanakan Sridharan; Saruja Nanthakumaran; Ashley A Arnold; Vanessa May; Bilal Haider Malik
Journal:  Cureus       Date:  2020-08-14

6.  Acute Kidney Injury following Rhabdomyolysis in Critically Ill Patients.

Authors:  Alvin Saverymuthu; Rufinah Teo; Jaafar Md Zain; Saw Kian Cheah; Aliza Mohamad Yusof; Raha Abdul Rahman
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-11-06

7.  Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.

Authors:  Lisa Kodadek; Samuel P Carmichael Ii; Anupamaa Seshadri; Abhijit Pathak; Jason Hoth; Rachel Appelbaum; Christopher P Michetti; Richard P Gonzalez
Journal:  Trauma Surg Acute Care Open       Date:  2022-01-27

8.  Role of bicarbonate and volume therapy in the prevention of acute kidney injury in rhabdomyolysis: a retrospective propensity score-matched cohort study.

Authors:  Hye Won Kim; Sejoong Kim; Jung Hun Ohn; Nak-Hyun Kim; Jongchan Lee; Eun Sun Kim; Yejee Lim; Jae Ho Cho; Hee Sun Park; Jiwon Ryu; Sun-Wook Kim
Journal:  Kidney Res Clin Pract       Date:  2021-12-02

9.  Cilastatin Ameliorates Rhabdomyolysis-induced AKI in Mice.

Authors:  Katsuyuki Matsushita; Kiyoshi Mori; Turgay Saritas; Mahaba B Eiwaz; Yoshio Funahashi; Megan N Nickerson; Jessica F Hebert; Adam C Munhall; James A McCormick; Motoko Yanagita; Michael P Hutchens
Journal:  J Am Soc Nephrol       Date:  2021-08-02       Impact factor: 14.978

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.